300740 Stock Overview
Engages in the research and development, production, and sale of cosmetic products in China. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 4/6 |
Financial Health | 3/6 |
Dividends | 2/6 |
Rewards
Risk Analysis
SYoung Group Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥12.30 |
52 Week High | CN¥20.55 |
52 Week Low | CN¥9.60 |
Beta | 1.14 |
11 Month Change | -11.57% |
3 Month Change | 21.30% |
1 Year Change | -27.00% |
33 Year Change | -25.32% |
5 Year Change | n/a |
Change since IPO | -19.08% |
Recent News & Updates
Recent updates
Shareholder Returns
300740 | CN Personal Products | CN Market | |
---|---|---|---|
7D | -4.1% | -2.8% | -2.1% |
1Y | -27.0% | -15.9% | 2.8% |
Return vs Industry: 300740 underperformed the CN Personal Products industry which returned -15.9% over the past year.
Return vs Market: 300740 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
300740 volatility | |
---|---|
300740 Average Weekly Movement | 9.4% |
Personal Products Industry Average Movement | 7.7% |
Market Average Movement | 8.4% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300740 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300740's weekly volatility (9%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 2,223 | Yuefeng Dai | www.syounggroup.com |
SYoung Group Co., Ltd. engages in the research and development, production, and sale of cosmetic products in China. The company provides facial masks and related products. It offers its products under the Yunifang, Xiaomimu, Dashuidi, Huayaohua, Yu, HPH, and VAA brands.
SYoung Group Co., Ltd. Fundamentals Summary
300740 fundamental statistics | |
---|---|
Market cap | CN¥4.78b |
Earnings (TTM) | CN¥208.48m |
Revenue (TTM) | CN¥4.16b |
22.9x
P/E Ratio1.1x
P/S RatioIs 300740 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300740 income statement (TTM) | |
---|---|
Revenue | CN¥4.16b |
Cost of Revenue | CN¥1.61b |
Gross Profit | CN¥2.55b |
Other Expenses | CN¥2.34b |
Earnings | CN¥208.48m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.54 |
Gross Margin | 61.23% |
Net Profit Margin | 5.01% |
Debt/Equity Ratio | 72.8% |
How did 300740 perform over the long term?
See historical performance and comparison